1125 related articles for article (PubMed ID: 10597778)
21. Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection.
Orendi JM; Bloem AC; Borleffs JC; Wijnholds FJ; de Vos NM; Nottet HS; Visser MR; Snippe H; Verhoef J; Boucher CA
J Infect Dis; 1998 Nov; 178(5):1279-87. PubMed ID: 9780247
[TBL] [Abstract][Full Text] [Related]
22. The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulation.
Cohen Stuart JW; Hazebergh MD; Hamann D; Otto SA; Borleffs JC; Miedema F; Boucher CA; de Boer RJ
J Acquir Immune Defic Syndr; 2000 Nov; 25(3):203-11. PubMed ID: 11115950
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
Kaufmann GR; Zaunders JJ; Cunningham P; Cooper DA
AIDS Res Hum Retroviruses; 1999 Jul; 15(11):963-72. PubMed ID: 10445808
[TBL] [Abstract][Full Text] [Related]
24. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
Gray CM; Schapiro JM; Winters MA; Merigan TC
AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
[TBL] [Abstract][Full Text] [Related]
25. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.
de Martino M; Rossi ME; Azzari C; Gelli MG; Galli L; Vierucci A
Pediatr Res; 1998 Jun; 43(6):752-8. PubMed ID: 9621984
[TBL] [Abstract][Full Text] [Related]
26. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.
Bouscarat F; Levacher-Clergeot M; Dazza MC; Strauss KW; Girard PM; Ruggeri C; Sinet M
AIDS Res Hum Retroviruses; 1996 Jan; 12(1):17-24. PubMed ID: 8825614
[TBL] [Abstract][Full Text] [Related]
27. Correlates of apoptosis of CD4+ and CD8+ T cells in tonsillar tissue in HIV type 1 infection.
Røsok BI; Brinchmann JE; Stent G; Bjerknes R; Voltersvik P; Olofsson J; Asjö B
AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1635-43. PubMed ID: 9870316
[TBL] [Abstract][Full Text] [Related]
28. Indicators of T-cell activation: correlation between quantitative CD38 expression and soluble CD8 levels in asymptomatic HIV+ individuals and healthy controls.
Lenkei R; Bratt G; Holmberg V; Muirhead K; Sandström E
Cytometry; 1998 Oct; 33(2):115-22. PubMed ID: 9773871
[TBL] [Abstract][Full Text] [Related]
29. Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells.
Evans TG; Bonnez W; Soucier HR; Fitzgerald T; Gibbons DC; Reichman RC
Antiviral Res; 1998 Oct; 39(3):163-73. PubMed ID: 9833957
[TBL] [Abstract][Full Text] [Related]
30. Major expansions of select CD8+ subsets in acute Epstein-Barr virus infection: comparison with chronic human immunodeficiency virus disease.
Lynne JE; Schmid I; Matud JL; Hirji K; Buessow S; Shlian DM; Giorgi JV
J Infect Dis; 1998 Apr; 177(4):1083-7. PubMed ID: 9534988
[TBL] [Abstract][Full Text] [Related]
31. 'Modeling' relationships among HIV-1 replication, immune activation and CD4+ T-cell losses using adjusted correlative analyses.
Lederman MM; Kalish LA; Asmuth D; Fiebig E; Mileno M; Busch MP
AIDS; 2000 May; 14(8):951-8. PubMed ID: 10853976
[TBL] [Abstract][Full Text] [Related]
32. Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.
Ganesh A; Lemongello D; Lee E; Peterson J; McLaughlin BE; Ferre AL; Gillespie GM; Fuchs D; Deeks SG; Hunt PW; Price RW; Spudich SS; Shacklett BL
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):791-800. PubMed ID: 27019338
[TBL] [Abstract][Full Text] [Related]
33. CD8+ T-cell activation in HIV-1-infected patients experiencing transient low-level viremia during antiretroviral therapy.
Taiwo B; Hunt PW; Gandhi RT; Ellingson A; McKenna M; Jacobson JM; Gripshover B; Bosch RJ
J Acquir Immune Defic Syndr; 2013 May; 63(1):101-4. PubMed ID: 23392463
[TBL] [Abstract][Full Text] [Related]
34. Markers of lymphocyte homing distinguish CD4 T cell subsets that turn over in response to HIV-1 infection in humans.
Hengel RL; Jones BM; Kennedy MS; Hubbard MR; McDougal JS
J Immunol; 1999 Sep; 163(6):3539-48. PubMed ID: 10477629
[TBL] [Abstract][Full Text] [Related]
35. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients.
Bofill M; Mocroft A; Lipman M; Medina E; Borthwick NJ; Sabin CA; Timms A; Winter M; Baptista L; Johnson MA; Lee CA; Phillips AN; Janossy G
AIDS; 1996 Jul; 10(8):827-34. PubMed ID: 8828739
[TBL] [Abstract][Full Text] [Related]
36. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
Mahalingam M; Pozniak A; McManus TJ; Vergani D; Peakman M
Clin Exp Immunol; 1995 Dec; 102(3):481-6. PubMed ID: 8536361
[TBL] [Abstract][Full Text] [Related]
37. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
Kestens L; Vanham G; Vereecken C; Vandenbruaene M; Vercauteren G; Colebunders RL; Gigase PL
Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
[TBL] [Abstract][Full Text] [Related]
38. Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy.
Ishizaka A; Sato H; Nakamura H; Koga M; Kikuchi T; Hosoya N; Koibuchi T; Nomoto A; Kawana-Tachikawa A; Mizutani T
J Virol; 2016 Jun; 90(12):5665-5676. PubMed ID: 27030274
[TBL] [Abstract][Full Text] [Related]
39. Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.
Al-Harthi L; Siegel J; Spritzler J; Pottage J; Agnoli M; Landay A
AIDS; 2000 May; 14(7):761-70. PubMed ID: 10839583
[TBL] [Abstract][Full Text] [Related]
40. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir.
Kelleher AD; Carr A; Zaunders J; Cooper DA
J Infect Dis; 1996 Feb; 173(2):321-9. PubMed ID: 8568292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
